Clinical Trial Update: MyoVista Measurements in Patients With Atherosclerosis and CAD

View source ↗

Summary

A clinical trial evaluating MyoVista measurements in patients with atherosclerosis and coronary artery disease has completed, according to the status update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Coronary Artery Disease (CAD), Atherosclerosis | Status: COMPLETED